The impact of EGFR T790M mutation status following the development of Osimertinib resistance on the efficacy of Osimertinib in non‐small cell lung cancer: A meta‐analysis.

Saved in:
Bibliographic Details
Title: The impact of EGFR T790M mutation status following the development of Osimertinib resistance on the efficacy of Osimertinib in non‐small cell lung cancer: A meta‐analysis.
Authors: Guo, Liuxian1,2 (AUTHOR), Zhou, Guojin1,2 (AUTHOR), Huang, Min2 (AUTHOR), Tang, Kejing1 (AUTHOR), Xu, Jing3 (AUTHOR), Chen, Jie1 (AUTHOR) chenj28@mail.sysu.edu.cn
Source: Clinical Respiratory Journal. Apr2024, Vol. 18 Issue 4, p1-14. 14p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first